Background and Objectives: HIV/AIDS has posed many unprecedented challenges. It causes a wide spectrum of disease manifestations. Approximately 60 % of the AIDS patients have neurological symptoms and 80-90 % have neuropathological abnormality at biopsy. The pattern of neurological complication in HIV infection in India is different from that of western countries. This study was under taken to, 1. Study the neurological manifestations in HIV patients admitted in to VIMS Hospital, Bellary. 2. To note differences with various studies carried out in western countries. Methods: Patients admitted in VIMS Hospital between December 2010 to June 2012 with symptoms referring to nervous system were screened and confirmed to have HIV-1 and/or HIV-2 infection (seropositive) by ICTC (Trispot test,Trilene test,Dot immunoassay )were enrolled if they met the inclusion criteria. Results: 58 of the 547 HIV positive patients fulfilled the inclusion criteria and were studied for neurological manifestations (10.6 %). 39 were males and 19 females and mean age of 34 yrs. in males and 29yrs in females. 62.1% were presenting with neurological symptoms and signs for the first time and were diagnosed HIV positive following admission. Meningitis was the commonest presentation (81.1%), 35(60.3%) patients with tubercular, 9(15.1%) patients with cryptococcal aetiology and 3(5.1%) had bacterial meningitis. Altered sensorium (75.6%), Headache (51.3 %), convulsions (32.4%) and focal neurological deficit (21.6 %) were the commonest presenting neurological symptoms with fever in 89.1 % of all cases. Tubercular involvement in form of meningitis (60.3%) and intracranial space occupying lesion (Tuberculoma) in 2 patients (3.4%) was the single largest etiological agent followed by cryptococcal meningitis 15.1%, 5 patients had CVA, 3 had bacterial meningitis, 2 had myelopathy, 1 had Bell's palsy and 1 patient had Guillain-Barre syndrome. No case of toxoplasmosis or lymphoma was detected. Interpretation and Conclusion : There is high incidence of neurological manifestations with tuberculosis and Cryptococci being commonest pathogenic agents in course of HIV infections in this study. Simple investigations like CD4 count may provide a clue to the degree of underlying immunosuppression and indicate the need to start ART in HIV/AIDS patients.
INTRODUCTION
AIDS was first recognized in the United States in the summer of 1981, when the U.S. Centre for Disease Control and Prevention (CDC) reported the unexplained occurrence of Pneumocystis jiroveci (formerly P. carinii) pneumonia in five previously healthy homosexual men in Los Angeles and of Kaposi's sarcoma (KS) with or without P. jiroveci pneumonia in 26 previously healthy homosexual men in New York and Los Angeles [1] . The HIV/AID Shasposed many unprecedented challenges. Further, owing to the insidious and covert nature of the disease, the problem is compounded by a prevailing attitude of denial or resistance of complacency at all levels. The visible manifestation of HIV occurs only at the last stage.
Original article As a result, there is a visible lack of realization of the problem in the society. The reactive response, therefore, does not match the real magnitude and gravity of the problem [2] . HIV and AIDS cause a wide spectrum of diseases and manifestation. Approximately 60 % of patients of AIDS have neurological symptoms and 80 to 90 % are found to have neuropathological abnormalities at autopsy [3] . Neurological complication of HIV infection cause considerable morbidity and are often associated with high mortality [4] . The pattern in India appears to differ from the classical literature in that neurotuberculosis leads the list of opportunistic infections [3] .
Indian Scenario
HIV/AIDS in India came into public view in 1986 with detection of first few cases of HIV in Chennai and first AIDS case in Mumbai in 1987. Presence of HIV-2 infection in India was reported for the first time from Mumbai in 1991 [5] . Though India is a country with low HIV prevalence, it has the third largest number of people living with HIV/AIDS. Based on HIV sentinel surveillance 2008-09, it is estimated that India has an adult prevalence of 0.31% with 23.9 lakh people infected with HIV, of which, 39 % (9.3 lakh) are female and 3.5 %are children, while 83 % are the in age group 15-49 years. It is estimated that India had approximately 1.2 lakh new HIV infections in 2009 [6] . from 26mg/dl to 450mg/dl with mean of 127 mg/dl. CSF abnormalities are seen in 67 % of the patients [7] .
MATERIAL AND METHODS

SOURCE OF DATA
Imaging
Total 49 cranial CTs and 2 MRI was done. 30 Cranial CT's were normal. The most common abnormality was cerebral oedema 8, inflammatory exudates 3,5 had hypo dense lesion suggestive of infract, single lesion-1, multiple lesions-1. Hydrocephalous 1, All mass / enhancing lesions were diagnosed to be tubercular granuloma based on clinical, CSF analysis and treatment response. 2 MRI taken from suspected myelitis cases showed changes suggestive demyelination in thoracic spinal cord. CT scan abnormalities are seen in 70 % of the patients76. Levy et al10 have reported [7] . Patients (5.46%) of AIDS with cerebrovascular complication -4 with infarcts (due to endocarditis). Mc. Arthur et al11 reported 9 cases (7%) of Cerebrovascular accidents (infarcts and Haemorrhage). Snider et al12 reported 6 (12%) cases and postulated granulomatous angitis as probable eitiopathology. Wadia et al13 in their study in Pune observed mass lesions in 16 % of the patients, single lesion in 24 and multiple lesions in 38. In the study by Puccioni et al14, 16 % had ringenhancing lesions, 18 % had non-enhancing lesions and 8 % had normal cranial CTs. Table 3 comparison of neurological manifestations CNS TB: HIV increases TB infection by 2 folds while AIDS increases by 5 folds. The commonest neurological complication of HIV infection in this study was due to tubercular involvement of the nervous system. It was seen in 37 patients (63.7%). Of them, 35 had tubercular meningitis, 2 had intracranial tuberculomas. The diagnosis was made based on clinical, imaging CSF analysis and response to treatment. The mean age at diagnosis was 33.4yrs. Tuberculosis was the presenting manifestation in 22 cases, 26 were males. 8 cases had associated pulmonary involvement. 7 patients had past history of tuberculosis, 2 had radiological abnormality suggestive of healed PTB (no history) and 6 had active PTB. CT scan was done in 29, showed cerebral oedema in 6, inflammatory exudates in 3, Multiple lesions in 1, single enhancing lesions in 1, hydrocephalous in 1 and 17 were normal Tuberculosis is wide-spread and rampant in our country, with a large segment of the population being constantly exposed to infection from open infected cases, irregular, incomplete therapy often results in partially treated and resistant cases. The poor hygiene and poor socio-economic states only compounds the problem. This accounts for the very high incidence of tubercular infection in HIV patients in our country. This is in contrast with the developed world where TB was almost eradicated and only the advent of HIV infection has seen the re-emergence of TB in the population.
Neurological Manifestations
Cryptococcal Meningitis
Meningitis manifested in 75 % of the cases. Tubercular meningitis was etiological agent in 35 cases (74.46%), Cryptococcus was the etiological agent in 9 cases (19.14%) and bacterial meningitis was seen in 3 cases (6.3%). Wadia et al63 reported meningitis in 17.88% of the 457 patients, Cryptococcal meningitis in 67.44% and tubercular in 18.60%. Table 5 Cryptococcal Meningitis comparisons. In this study 9 patients were diagnosed to have Cryptococcal meningitis based on CSF India ink preparation. Mean age 34yrs, 6 males and 3 females. 7 had fever, 8 had headache and altered sensorium was seen in 1 patient, 2 had convulsions and history of weight loss was present in 5 cases. Candidiasis was seen with 4 patients. Signs of meningeal irritation were present in6 cases. CSF analysis showed mean cell count of 67 per cumm, mean protein 100mg/dl and mean sugar of 40mg/ dl. Cryptococcal antigen detection and culture was not carried out due to cost constraints and CSF India ink was the diagnostic criteria for all cases. Chunk et al18 found CSF India ink preparation for Cryptococci positive in only 50-70% of cases while Fernandes et al showed Indian ink positivity in 55% of cases. Hence a number of patients with Cryptococcal meningitis may have been missed in this study. Mean CD4 count was111, ranging from 34 to 262, 6 cases had count <100. Cranial CT was done in 8 cases. 7 were normal and 1 cerebral oedema. Levy et al10 reported 16 patients with Cryptococcal meningitis in their study, one of who developed an intracerebral cryptococcoma. They reported the few of their patients had no neurological sign and symptoms except for headache and subtle altered sensorium. Neuroimaging as well as routing CSF examination may be normal on many occasions. Chuck et al51 in their study of 89 patients found that 
Conclusion
• The following are the conclusion drawn from this study: • The percentage of HIV patients with neurological manifestation is 10.6 % over 19 month study period and is on the rise.
• Neurological manifestations heralded HIV in 62 % of patients.
• Young adults are mainly affected.
• Sexual activity with CSWs is the major mode of transmission.
• Meningitis was the commonest manifestation 81%. 47 out of 58 patients comprising of 35 cases of Tubercular Meningitis, 9 cases of Cryptococcal Meningitis and 3 cases of bacterial meningitis.
• Tuberculosis is the commonest disease affecting nervous system (39/58) with 2 of these patients having intracranial space occupying lesion (tuberculoma) and rest meningitis.
• Neuroimaging studies and CSF analysis are useful in diagnosing in opportunistic infections of the nervous system. • High index of suspicion is necessary to detect HIV in patients presenting with neurological symptom and to diagnose and treat the underlying cause.
• This is a small study carried out over stipulated period of time in a small population and does not indicate the true incidence or prevalence of the disease in the community. It is important that we continue to develop new diagnostic tools, new therapies and new strategies for managing these complications of immune dysfunction.
